2025 NOSCM | Multi-Use of Liquid Biopsies: From Early Detection to Therapy Selection

2025 NOSCM | Multi-Use of Liquid Biopsies: From Early Detection to Therapy Selection

Overview

Paula Mota de Sá highlighted liquid biopsies' role in cancer care—including early detection, therapy guidance, and MRD monitoring. Though minimally invasive and informative, they face standardization and sensitivity issues. Studies show promise but need further validation.

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Paula Mota de Sá, PhD

Date of Release

July 20th, 2025